Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
IHIT Stock Summary
In the News
CEF Weekly Review: High Premium Funds Fold
We review CEF market valuation and performance through the fourth week of October and highlight recent market action. CEFs experienced another tough week, with most sectors in the red for the month of October. October once again highlighted the procyclical nature of CEF discounts, with high premium funds deflating more during difficult market periods.
CEF Weekly Review: What Drives CEF Portfolio Turnover Costs?
CEF Weekly Review: What Drives CEF Portfolio Turnover Costs?
CEF Weekly Review: Is There Value In Knowing CEF Institutional Investor Holdings?
We review CEF market valuation and performance through the last week of September and highlight recent market action. CEFs finished September on a weak note, with all sector NAVs moving lower as Treasuries and stocks fell. Investors should be careful in assuming some level of institutional ownership indicates a buy signal for a given CEF.
IHIT: Disappointing Performance (Rating Downgrade)
The Invesco High Income 2023 Target Term Fund is a closed-end fund that invests in commercial mortgage-backed securities. The CMBS market is facing a debt maturity wall, with the current interest rate environment making it difficult for borrowers to refinance. IHIT has a term structure that means it will have to liquidate its portfolio by December 2023, even if the underlying assets are underwater.
CEF Weekly Review: Analysis Mistakes Can Lead Investors Astray
We review CEF market valuation and performance through the fourth week of June and highlight recent market action. CEFs gave back some of their previous rallies as risk sentiment pulled back. We take a look at a couple of misconceptions we came across this week with regard to CEFs and which can lead investors astray in their allocation decisions.
CEF Weekly Review: Watch Out For CEF Triple Whammies
We review CEF market valuation and performance through the third week of June and highlight recent market action. CEFs were mostly up on the week due to improving risk sentiment. We discuss a common CEF triple whammy that investors ought to be aware of.
CEF Weekly Review: Term CEFs Continue To Be Misunderstood
We review CEF market valuation and performance through the third week of May and highlight recent market action. CEFs were mostly down on the week as rising Treasury yields were the key headwind.
IHIT Vs. BSCN: 2 Invesco Bond Funds That Terminate In 2023
The Invesco High Income 2023 Target Term Fund (IHIT) terminates near 12/1/23, with a payout goal of $9.835. The Invesco BulletShares 2023 Corporate Bond ETF (BSCN) terminates near 12/15/23. Unlike IHIT, Invesco did not set a payout goal for this ETF.
IHIT: You Could Get An 8% Risk-Free Return Here In 2023
Invesco High Income 2023 Target Term Fund is a CMBS closed end fund. The CEF has a December 1, 2023 target liquidation date.
Quality Closed-End Fund Report, February 2022
Only funds with coverage >100% are considered. Top lists of discount, yield, DxY and DxYxZ are given. Top DxYxZ funds are EHI, JPI and WEA.
IHIT Financial details
IHIT Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-02-28
Metric | History | 2019-02-28 | 2020-02-29 | 2021-02-28 | 2022-02-28 | 2023-02-28 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.86 | 1.03 | -0.86 | 0.53 | -0.24 | |
Net income per share | 0.85 | 1.01 | -0.87 | 0.52 | -0.25 | |
Operating cash flow per share | 0.57 | 0.6 | 0.83 | 0.34 | 0.45 | |
Free cash flow per share | 0.57 | 0.6 | 0.83 | 0.34 | 0.45 | |
Cash per share | 0.02 | 0.02 | 0 | 0.04 | 0 | |
Book value per share | 10.21 | 10.7 | 9.21 | 9.03 | 8.4 | |
Tangible book value per share | 10.21 | 10.7 | 9.21 | 9.03 | 8.4 | |
Share holders equity per share | 10.21 | 10.7 | 9.21 | 9.03 | 8.4 | |
Interest debt per share | 3.46 | 3.48 | 3.41 | 3.33 | 3.44 | |
Market cap | 243.63M | 247.69M | 217.97M | 214.33M | 197.51M | |
Enterprise value | 323.07M | 327.11M | 297.84M | 293.3M | 276.94M | |
P/E ratio | 11.94 | 10.3 | -10.49 | 16.92 | -32.4 | |
Price to sales ratio | 11.77 | 10.12 | -10.6 | 16.58 | -34.34 | |
POCF ratio | 17.79 | 17.36 | 10.94 | 25.85 | 18.14 | |
PFCF ratio | 17.79 | 17.36 | 10.94 | 25.85 | 18.14 | |
P/B Ratio | 0.99 | 0.97 | 0.99 | 0.97 | 0.97 | |
PTB ratio | 0.99 | 0.97 | 0.99 | 0.97 | 0.97 | |
EV to sales | 15.6 | 13.37 | -14.48 | 22.69 | -48.15 | |
Enterprise value over EBITDA | -189.48 | 548.42 | -7.64 | -76.62 | -11.88 | |
EV to operating cash flow | 23.6 | 22.93 | 14.95 | 35.38 | 25.43 | |
EV to free cash flow | 23.6 | 22.93 | 14.95 | 35.38 | 25.43 | |
Earnings yield | 0.08 | 0.1 | -0.1 | 0.06 | -0.03 | |
Free cash flow yield | 0.06 | 0.06 | 0.09 | 0.04 | 0.06 | |
Debt to equity | 0.33 | 0.31 | 0.36 | 0.36 | 0.39 | |
Debt to assets | 0.25 | 0.24 | 0.27 | 0.27 | 0.28 | |
Net debt to EBITDA | -46.59 | 133.15 | -2.05 | -20.63 | -3.41 | |
Current ratio | 8.84 | 5.27 | 5.95 | 6.3 | 8.71 | |
Interest coverage | 5.99 | 5.84 | 12.02 | 14.97 | 5.53 | |
Income quality | 0.67 | 0.59 | -0.96 | 0.65 | -1.79 | |
Dividend Yield | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | |
Payout ratio | 0.7 | 0.59 | -0.67 | 0.99 | -1.81 | |
Sales general and administrative to revenue | 0.01 | 0.01 | -0.01 | 0.02 | -0.06 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 13.97 | 15.6 | 13.43 | 10.28 | 6.91 | |
ROIC | 0.06 | 0.05 | -0.05 | 0.07 | -0.16 | |
Return on tangible assets | 0.06 | 0.07 | -0.07 | 0.04 | -0.02 | |
Graham Net | -3.27 | -3.27 | -3.31 | -3.22 | -3.28 | |
Working capital | 1.97M | 2.72M | 1.29M | 2.04M | 2.39M | |
Tangible asset value | 244.95M | 254.88M | 219.89M | 220.01M | 202.9M | |
Net current asset value | -78.04M | -77.29M | -78.72M | -77.99M | -77.63M | |
Invested capital | 0.33 | 0.31 | 0.36 | 0.36 | 0.39 | |
Average receivables | 1.59M | 2.22M | 2.11M | 1.41M | 1.4M | |
Average payables | 115.68K | 98.25K | 93.07K | 86.56K | 73.2K | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 29.21 | 41.5 | -25.38 | 39.54 | -89.03 | |
Days payables outstanding | 0 | 6.5 | -0.96 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 12.5 | 8.79 | -14.38 | 9.23 | -4.1 | |
Payables turnover | 0 | 56.12 | -381.13 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.08 | 0.09 | -0.09 | 0.06 | -0.03 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-02-28 for Q4
Metric | History | 2022-02-28 | 2022-05-31 | 2022-08-31 | 2022-11-30 | 2023-02-28 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.19 | 0.2 | 0.2 | 0.19 | 0.19 | |
Net income per share | -0.02 | -0.04 | -0.04 | -0.09 | -0.09 | |
Operating cash flow per share | 0.13 | 0.22 | 0.22 | 0 | 0 | |
Free cash flow per share | 0.13 | 0.22 | 0.22 | 0 | 0 | |
Cash per share | 0.04 | 0.07 | 0.07 | 0.02 | 0 | |
Book value per share | 9.11 | 8.79 | 8.79 | 8.4 | 8.4 | |
Tangible book value per share | 9.11 | 8.79 | 8.79 | 8.4 | 8.4 | |
Share holders equity per share | 9.11 | 8.79 | 8.79 | 8.4 | 8.4 | |
Interest debt per share | 3.31 | 3.31 | 3.31 | 3.34 | 3.34 | |
Market cap | 212.43M | 210.5M | 207.12M | 209.58M | 197.51M | |
Enterprise value | 291.4M | 208.87M | 285.49M | 209.01M | 276.94M | |
P/E ratio | -90.2 | -57.17 | -56.25 | -24.63 | -23.21 | |
Price to sales ratio | 46.5 | 44.19 | 43.48 | 44.87 | 42.29 | |
POCF ratio | 69.48 | 39.36 | 38.73 | 2.15K | 2.03K | |
PFCF ratio | 69.48 | 39.36 | 38.73 | 2.15K | 2.03K | |
P/B Ratio | 0.97 | 0.99 | 0.98 | 1.03 | 0.97 | |
PTB ratio | 0.97 | 0.99 | 0.98 | 1.03 | 0.97 | |
EV to sales | 63.79 | 43.84 | 59.93 | 44.75 | 59.29 | |
Enterprise value over EBITDA | -63.81 | -40.83 | -55.81 | -30.56 | -40.49 | |
EV to operating cash flow | 95.31 | 39.06 | 53.38 | 2.15K | 2.84K | |
EV to free cash flow | 95.31 | 39.06 | 53.38 | 2.15K | 2.84K | |
Earnings yield | 0 | 0 | 0 | -0.01 | -0.01 | |
Free cash flow yield | 0.01 | 0.03 | 0.03 | 0 | 0 | |
Debt to equity | 0.36 | 0.38 | 0.38 | 0.39 | 0.39 | |
Debt to assets | 0.27 | 0.27 | 0.27 | 0.28 | 0.28 | |
Net debt to EBITDA | -17.29 | 0.32 | -15.32 | 0.08 | -11.61 | |
Current ratio | 6.3 | 0.75 | 0.75 | 8.71 | 8.71 | |
Interest coverage | 0 | 0 | 0 | 6.18 | 6.18 | |
Income quality | -5.19 | -5.81 | -5.81 | -0.05 | -0.05 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Payout ratio | -5.14 | -3.23 | -3.23 | -1.2 | -1.2 | |
Sales general and administrative to revenue | 0.13 | 0.12 | 0.12 | 0.13 | 0.13 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 2.24 | 2.75 | 2.75 | 4.08 | 4.08 | |
ROIC | -0.09 | -0.07 | -0.07 | -0.03 | -0.03 | |
Return on tangible assets | 0 | 0 | 0 | -0.01 | -0.01 | |
Graham Net | -3.25 | -3.46 | -3.41 | -3.3 | -3.28 | |
Working capital | 2.04M | -1.29M | -1.29M | 2.39M | 2.39M | |
Tangible asset value | 220.01M | 212.24M | 212.24M | 202.9M | 202.9M | |
Net current asset value | -77.99M | -81.32M | -81.32M | -77.63M | -77.63M | |
Invested capital | 0.36 | 0.38 | 0.38 | 0.39 | 0.39 | |
Average receivables | 700.09K | 700.09K | 840.73K | 840.73K | 701.44K | |
Average payables | 36.14K | 2.51M | 4.98M | 2.51M | 37.06K | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 27.59 | 0 | 31.77 | 0 | 27.03 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 3.26 | 0 | 2.83 | 0 | 3.33 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | -0.01 | -0.01 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
IHIT Frequently Asked Questions
What is Invesco High Income 2023 Target Term Fund stock symbol ?
Invesco High Income 2023 Target Term Fund is a US stock , located in Atlanta of Ga and trading under the symbol IHIT
What is Invesco High Income 2023 Target Term Fund stock quote today ?
Invesco High Income 2023 Target Term Fund stock price is $6.92 today.
Is Invesco High Income 2023 Target Term Fund stock public?
Yes, Invesco High Income 2023 Target Term Fund is a publicly traded company.